Company: PTHS
Filing Date: 2025-11-25
Form Type: DEF 14A
Source: 0001753926-25-001827
Chunk: 7

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-25
Form: DEF 14A
Chunk 7
---
 named executive officers; and (iv)
all of our directors and named executive officers as a group.

Beneficial ownership in accordance with the rules of the SEC, and thus it represents sole or shared voting or investment power with respect to our securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares that they beneficially owned, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of Sections 13(d) and 13(g) of the Exchange Act.

The percentage of beneficial ownership is calculated based on 3,086,681 shares of Common Stock outstanding as of November 24, 2025. The number of shares beneficially owned includes shares of Common Stock that each person has the right to acquire within 60 days of November 24, 2025, including upon the exercise of stock options or conversion of restricted stock units (“RSU”). These stock options shall be deemed to be outstanding for the purpose of computing the percentage of outstanding shares of Common Stock expected to be owned by such person but shall not be deemed to be outstanding for the purpose of computing the percentage of outstanding shares of the combined organization’s Common Stock expected to be owned by any other person.

Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Pelthos Therapeutics Inc., 4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703.

On February 15, 2024 the Company effected
a one-for-nine reverse stock split of its outstanding Common Stock, and on July 1, 2025, the Company effected a one-for-ten reverse
stock split of its outstanding Common Stock (the “Reverse Stock Splits”). All share amounts in this Proxy Statement
have been retroactively adjusted to reflect the Reverse Stock Splits.

| Shares                                       
 Beneficially Owned                           |     |              |           |     |              |      |   |
| Name                                         
 of Beneficial Owner                          |     | Number       
 of           
 Shares       
 Beneficially 
 Owned        |           |     | Percentage   
 of           
 Shares       
 Beneficially 
 Owned        
 (%)          |      |   |
| 5% shareholders:                             |     |              |           |     |              |      |   |
| 3i LP(1)                                     |     |              |   500,000 |     |              |